Does MITOXANTRONE Cause Malignant neoplasm progression? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Malignant neoplasm progression have been filed in association with MITOXANTRONE (mitoXANTRONE). This represents 1.7% of all adverse event reports for MITOXANTRONE.
70
Reports of Malignant neoplasm progression with MITOXANTRONE
1.7%
of all MITOXANTRONE reports
25
Deaths
23
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MITOXANTRONE?
Of the 70 reports, 25 (35.7%) resulted in death, 23 (32.9%) required hospitalization, and 2 (2.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MITOXANTRONE. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does MITOXANTRONE Cause?
Febrile neutropenia (668)
Off label use (368)
Neutropenia (296)
Drug ineffective (293)
Thrombocytopenia (256)
Sepsis (240)
Pyrexia (214)
Product use in unapproved indication (177)
Disease progression (173)
Acute myeloid leukaemia (167)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MITOXANTRONE Alternatives Have Lower Malignant neoplasm progression Risk?
MITOXANTRONE vs MITRAGYNINE\HERBALS
MITOXANTRONE vs MIZORIBINE
MITOXANTRONE vs MOBOCERTINIB
MITOXANTRONE vs MOCLOBEMIDE
MITOXANTRONE vs MODAFINIL